NRx Pharmaceuticals (NASDAQ: NRXP), announced that CEO and Chairman Prof. Jonathan Javitt, MD, MPH will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on July 29–30, 2025.

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), today announced that its CEO and Chairman ...

AppLovin Corporation (NASDAQ:APP) is one of the best multibagger stocks according to hedge funds. On July 23, 2025, BTIG ...

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the ...

Lucid Diagnostics' EsoGuard test may soon gain Medicare coverage, boosting its market potential. Read more here.

Kirby Corporation (NYSE:KEX) is one of the best shipping and container stocks to invest in now. On June 27, analyst Gregory ...

Investing.com -- In a note to clients on Wednesday, BTIG downgraded Unity shares to Sell from Neutral, arguing that the stock ...

The stock market may soon face a pullback based on technical indicators, according to Jonathan Krinsky, managing director and chief market technician at BTIG. The S&P 500 is on track to close above ...

BTIG’s assessment suggested the company leveraged favorable industry trends and gained market share as it heads into earnings ...

However, BTIG analysts argue that this complexity adds value, particularly as it aligns with the company’s strengths in real estate and structured credit. Overall, BTIG’s reaffirmation of the Buy ...

Consequently, BTIG has increased their EPS estimates for Taylor Morrison, with expectations for 2025 rising to $8.40 from $7.60, and for 2026 to $8.80 from $7.90. The analysts at BTIG believe that ...